Hui K. Gan And NotPrognostic
List of bibliographic references
Number of relevant bibliographic references: 8.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000E37 | Julien Péron [Canada] ; Denis Maillet ; Hui K. Gan ; Eric X. Chen ; Benoit You | Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. |
| 000F64 | Julien Peron [France] ; Denis Maillet [France] ; Hui K. Gan [Australie] ; Eric X. Chen [Canada] ; Benoit You [France] | Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review |
| 001007 | Christophe Le Tourneau [France] ; Hui K. Gan [Australie] ; Albiruni R. A. Razak [Canada] ; Xavier Paoletti [France] | Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents |
| 001107 | Julien Peron [France] ; Gregory R. Pond [Canada] ; Hui K. Gan [Australie] ; Eric X. Chen [Canada] ; Roula Almufti [France] ; Denis Maillet [France] ; Benoit You [France] | Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review |
| 001156 | Benoit You [Canada, France] ; Hui K. Gan [Canada, Australie] ; Gregory Pond [Canada] ; Eric X. Chen [Canada] | Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review |
| 001172 | Hui K. Gan [Australie] ; Benoit You [Canada, France] ; Gregory R. Pond [Canada] ; Eric X. Chen [Canada] | Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer |
| 001323 | Christophe Le Tourneau [France] ; Albiruni R. A. Razak [Canada] ; Christine Levy [France] ; Valentin Calugaru [France] ; Olivier Galatoire [France] ; Remi Dendale [France] ; Laurence Desjardins [France] ; Hui K. Gan [Australie] | Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland |
| 001367 | Christophe Le Tourneau [France] ; Albiruni R. A. Razak [Canada] ; Hui K. Gan [Australie] ; Simona Pop [France] ; Véronique Dieras [France] ; Patricia Tresca [France] ; Xavier Paoletti [France] | Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: A review of the literature |
| This area was generated with Dilib version V0.6.33. |  |